ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

Go back to ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
(NASDAQ: SPRY) Delayed: 4.11 -0.04 (0.96%)
Previous Close $4.15    52 Week High
Open $4.10    52 Week Low
Day High $4.20    P/E N/A 
Day Low $4.10    EPS
Volume 1,885,771